Palo Alto Investors »

Caredx shares owned by Palo Alto Investors

Quarter-by-quarter ownership of Caredx (CDNA) shares owned by Palo Alto Investors from 13F filings

Historical chart of Palo Alto Investors investment in Caredx

Tip: Access up to 7 years of quarterly data

All positions including Caredx held by Palo Alto Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Caredx by Palo Alto Investors

Quarter filed Position value Share count Share price at filing
2026-03-31 $9.2M 532k 17.36
2025-12-31 $9.0M 478k 18.84
2025-09-30 $4.6M 316k 14.54

More positions owned by Palo Alto Investors

Insmed Com Par $.01 (INSM)
ACADIA Pharmaceuticals (ACAD)
Ptc Therapeutics I (PTCT)
BioMarin Pharmaceutical (BMRN)
United Therapeutics Corporation (UTHR)
Anaptysbio Inc Common (ANAB)
Mirum Pharmaceuticals (MIRM)
Dyne Therapeutics (DYN)
Biogen Idec (BIIB)
Disc Medicine (IRON)
Iovance Biotherapeutics (IOVA)
Syndax Pharmaceuticals (SNDX)
Annexon (ANNX)
Amicus Therapeutics (FOLD)
Novocure Ord Shs (NVCR)

View all positions for Palo Alto Investors

Top funds holding Caredx

BlackRock
Vanguard Group
Bamco
State Street Corporation
ARK Investment Management
Deerfield Management Company
Braidwell
Vanguard Capital Management
Robeco Investment Management
Gagnon Securities
Chevy Chase Trust Holdings
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Dimensional Fund Advisors
Geode Capital Management

View all funds holding Caredx